Form 4: Tandem Diabetes Care Executive Rick Carpenter Reports Stock Transactions
SEC Form 4 Filing
Rick Carpenter, Chief Technology Officer at Tandem Diabetes Care, reported the vesting of restricted stock units and the subsequent withholding of shares for tax purposes.
Summary
- Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, filed a Form 4 detailing changes in his beneficial ownership of company stock.
- On December 16, 2024, 406 restricted stock units (RSUs) vested, converting into common stock.
- A portion of the vested shares, specifically 145 shares, were withheld by the company to cover tax obligations.
- The price per share for the tax withholding was $32.66.
- Following these transactions, Carpenter's direct holdings decreased to 14,935 shares of common stock and 1,624 RSUs.
Sentiment
Score: 7
Explanation: The document is a routine filing of stock transactions, which is neutral to slightly positive as it indicates the executive is receiving compensation in the form of company stock. There is no indication of any negative sentiment.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It provides transparency into the stock transactions of company insiders.
Comparison to Industry Standards
- Stock-based compensation is a common practice in the technology and medical device industries, with companies like Dexcom and Insulet also using RSUs as part of their executive compensation packages.
- The vesting schedule of 25% initially and then quarterly installments is a fairly standard approach for RSU grants.
- The tax withholding process is also a standard practice to cover the tax liabilities associated with the vesting of RSUs.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects a change in insider ownership, but it is a normal part of executive compensation.
- The transaction has no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/15/2021 | Date of the original grant of the restricted stock units. |
| 12/15/2022 | Date when 25% of the RSUs vested. |
| 12/16/2024 | Date of the reported stock transaction and vesting of RSUs. |
| 12/18/2024 | Date the Form 4 was signed. |
Keywords
Tandem Diabetes Care, stock transaction, Form 4, restricted stock units, RSU, insider trading, executive compensation, tax withholding, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.